Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Agilent Technologies Inc (A) vs Zoetis Inc (ZTS) Price & Performance

Agilent Technologies IncTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Agilent Technologies Inc vs Zoetis Inc — how do they compare? Agilent Technologies Inc trades at $148.72 (market cap $42.22B), while Zoetis Inc trades at $75.11 (market cap $31.14B). The key difference: Agilent Technologies Inc is the larger of the two by market cap, and Zoetis Inc pays the higher dividend (2.81%). Which is the better fit depends on your goals.

AZTS
Market Cap
$42.22B$31.14B
Sector
HealthHealth
52-Week High
$157.20$156.76
52-Week Low
$110.24$71.91
Enterprise Value
$43.77B$38.70B
Dividend Yield
0.68%2.81%

Returns comparison

Trailing returns across standard periods

About Agilent Technologies Inc

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.

Read more on A

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS